Page 7 - Advm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Equities analysts expect Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) to report earnings of ($0.34) per share for the current quarter, according to Zacks. Zero analysts have made estimates for Adverum Biotechnologies’ earnings. The lowest EPS estimate is ($0.35) and the highest is ($0.33). Adverum Biotechnologies reported earnings of ($0.29) per share in the same […]

Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) CEO Laurent Fischer acquired 25,000 shares of the business’s stock in a transaction dated Wednesday, April 20th. The stock was acquired at an average cost of $1.11 per share, for a total transaction of $27,750.00. Following the transaction, the chief executive officer now owns 762,462 shares of the […]

Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) insider Peter Soparkar purchased 21,925 shares of Adverum Biotechnologies stock in a transaction that occurred on Tuesday, April 19th. The shares were bought at an average price of $1.14 per share, with a total value of $24,994.50. Following the completion of the transaction, the insider now owns 280,556 […]

Brokerages expect Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) to report ($0.34) earnings per share for the current fiscal quarter, according to Zacks. Zero analysts have made estimates for Adverum Biotechnologies’ earnings. The highest EPS estimate is ($0.33) and the lowest is ($0.35). Adverum Biotechnologies posted earnings of ($0.29) per share in the same quarter […]

StockNews.com started coverage on shares of Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) in a report released on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, Zacks Investment Research raised shares of Adverum Biotechnologies from a hold rating to a buy rating and set a $2.00 price target for the company […]